Exploratory Study Evaluating the Effects of Dermo-cosmetic RV5026B Applied for 2 Months in Adults With Erythrocouperosis
Status:
TERMINATED
Trial end date:
2025-02-20
Target enrollment:
Participant gender:
Summary
This exploratory study aims to evaluate the effects of the test product RV5026B - ET1732 on erythema, as well as on the sensations of discomfort and relief perceived in subjects with erythrocouperose and associated pityriasis folliculorum.
We wish to evaluate:
* firstly the test product alone in order to quantify the effects on the signs \& symptoms on the entire face,
* then the contribution of the test product in addition to a reference topical treatment.
The test product RV5026B - ET1732 was developed to:
* Reduce redness, even if it has already set in, and help limit its reappearance
* Soothe the sensations of heating and discomfort associated